Follow the people · Insider

CH

Craig C. Hopkinson

Insider · EVP R&D, Chief Medical Officer · ALKS

Craig C. Hopkinson files insider transactions with the SEC as an evp r&d, chief medical officer of Alkermes plc (ALKS). We hold 10 disclosed purchases and sales filed since 21 February 2018, 3 of them in the last 90 days.

  • Files forALKS
  • Disclosed buys and sells10 in all, 3 in the last 90 days
  • Last disclosure1 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 16 February 20181 September 2026EVP R&D, Chief Medical Officer · Alkermes plc (ALKS)242 Form 4 lines · source: SEC Form 4
  • Filed 1 December 20222 March 2023Director · Albireo Pharma (ALBO)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.